The rationale and requirements for the development of boron neutron capture therapy of brain tumors

Journal of Neuro-Oncology

Volumn 33, Issue 1-2, 1997, Pages 09-18

  Soloway, Albert H ^a   Barth, Rolf F ^a   Gahbauer, Reinhard A ^a   Blue, Thomas E ^a   Goodman, Joseph H ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Binary systems; Boron compounds; Boron neutron capture therapy; Glioblastoma multiforme; Neutrons; Therapy

Indexed keywords

ANTIBIOTIC AGENT; ANTIMETABOLITE; BORON 10; BORON DERIVATIVE; FOLIC ACID DERIVATIVE; NITROSOUREA; PURINE DERIVATIVE;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG SYNTHESIS; DRUG TARGETING; GLIOBLASTOMA; HUMAN; NEUTRON CAPTURE THERAPY; NUCLEAR REACTOR; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR CELL;

EID: 0030890818     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1005753610355     Document Type: Article

References (43)

1. Wingo PA, Tong T, Bolden S: Cancer Statistics 1995. CA Cancer J Clin 45: 8-30, 1995
2. Prados MD, Wilson CB: Neoplasms of the central nervous system. In: Holland JF, Frei III E, Bast Jr RC, Kufe DW, Morton DL, Weichselbaum RR (eds) Cancer Medicine Vol. 1. Lea Febiger 1080-1119, 1993
3. Barth RF: Biologic consideration in targeting brain tumors for boron neutron capture therapy. In: Mishima Y (ed) Cancer Neutron Capture Therapy. Plenum Press, New York, 533-540, 1996
4. Sano K: The future role of neurosurgery in the case of cerebral tumors. Neurosurg Rev 9: 13-22, 1986
5. Fulton D S, Urtasun RC, Scott-Brown I: Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. J Neuro-Oncol 14: 63-72, 1992
6. Larson DA, Sneed PK, Gutin PH: International brachytherapy for recurrent malignant gliomas. In: Karim ABMF, Laws Jr ER (eds) Glioma. Springer Verlag, Heidelberg 205-215, 1991
7. Warnke PC, Ostertag CB: Physiology of stereotactic interstitial radiosurgery. In: Amaldi V, Larsson B (eds) Hadron-therapy in Oncology. Elsevier, Amsterdam 657-663, 1994
8. Loeffler JS, Shrieve DC, Tarbell N, Alexander III E: External stereotactic radiation techniques for intracranial lesions. In: Kogelnik HD (ed) Progress in Radio-oncology V. Monduzzi, Bologna 389-396, 1995
9. Catterall M, Bloom HJG, Ash DV, Walsh L, Richardson A, Utley D, Goiving NFC, Lewis P, Chaucer B: Fast neutrons compared with megavoltage X-rays in the treatment of patients with supratentorial glioblastoma: a controlled pilot study. Int J Rad Oncol Biol Phys 6: 261-266, 1980
10. Laramore GE, Griffin TW, Gerdes AJ, Parker RG: Fast neutron and mixed (neutron/photon) BEA teletherapy for grades III and IV astrocytoma. Cancer 42: 96-103, 1978
11. Kurup PD, Payak TF, Nelson JS, Mansell J, Hendrickson FR, Cohen L, Griffin TW: Fast neutron therapy for malignant astocytomas. J Neuro-Oncol 4: 123-129, 1986
12. Laramore GE, Diener-West M, Griffin TW, Nelson JS, Griem ML, Thomas FG, Hendrickson FR, Griffin BR, Myrainthopoulas LC, Saxton J: Randomized neutron dose searching study for malignant gliomas of the brain: results of an RTOG study. Int J Rad Oncol Biol Phys 14: 1093-1102, 1988
13. Flowers A, Levin VA: Chemotherapy for brain tumors. In: Kaye H, LawsJr ER (eds) Brain Tumors: An Encyclopedic Approach. Churchill Livingstone, Edinburgh 349-360, 1995
14. Neuwelt EA, Goldman DL, Dahlborgh SA, Crossen J, Ramsey F, Braziel R, Roman-Goldstein S, Braziel R, Dana B: Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: Prolonged survival and preservation of cognitive function. J Clin Oncol 9: 1580-1590, 1991
15. Salcman M: Experimental therapy for brain tumors. In: Kaye AH, Laws Jr ER (eds) Brain Tumors: An Encyclopedic Approach. Churchill Livingstone, Edinburgh 369-385, 1995
16. 10 in therapy of intracranial tumors. Trans Am Neurol Assoc 76: 60-63, 1951
17. Friedlander G, Kennedy JW, Macias ES, Miller JM: Nuclear and Radiochemistry, 3rd ed. John Wiley & Sons, New York 610-650, 1981
18. 10. Cancer 8: 601-615, 1955
19. Asbury AK, Ojemann RG, Nielsen SL, Sweet WH: Neuropathological study of 14 cases of malignant brain tumor treated by boron-10 slow neutron capture radiation. J Neuropathol Exp Neurol 31: 278-303, 1971
20. Soloway AH, Hatanaka H, Davis MA: Penetration of brain and brain tumor: VII tumor-binding sulfhydryl boron compounds. J Med Chem 10: 714-717, 1967
21. Snyder HR, Reedy AJ, Lennarz WJ: Synthesis of aromatic boronic acids, aldehyde boronic acids and a boronic acid analog of tyrosine. J Am Chem Soc 80: 835-838, 1958
22. Fairchild RG, Saraf SK, Kalef-Ezra J, Laster BH: Comparison of measured parameters from a 24-keV and a broad spectrum epithermal neutron beam for neutron capture therapy: an identification of consequential parameters. Med Phys 17: 1045-1052, 1990
23. Lemmen P, Werner B, Streiches B: Ether lipids as potential boron carriers for boron neutron capture therapy: synthesis of rac-1-(9-0-carboranyl)nonyl-2-methyl-glycero-3-phosphochilone (B-Et-11-OMe). In: Soloway AH, Barth RF, Carpenter DE (eds) Advances in Neutron Capture Therapy. Plenum Press, New York 297-300, 1993
24. Wyzlic IM, Tjarks W, Soloway AH, Anisuzzaman AKM, Rong F-G, Barth RF: Strategies for the design and synthesis of boronated nucleic acid and protein components as potential delivery agents for neutron capture therapy. Int J Rad Oncol Biol Phys 28: 1203-1213, 1994
25. Rong F-G, Soloway AH: Synthesis of 5-tethered carborane-containing pyrimidine nucleosides as potential agents for DNA incorporation. Nucleosides + Nucleotides 13: 2021-2034, 1994
26. Kahl SB, Koo M-S: Synthesis and properties of tetrakis-carborane-carboxylate esters of 2,4-bis-(αmβ-dihydroxyethyl) deuteroporphyrin IX. In: Allen BJ, Moore DE, Harrington BV (eds) Progress in Neutron Capture Therapy for Cancer. Plenum Press, New York 223-226, 1992
27. Tjarks W, Malmquist J, Gedda L, Sjöberg S, Carlsson J: Synthesis and initial biological evaluation of carborane-containing phenanthridinium derivatives. In: Mishima Y (ed) Cancer Neutron Capture Therapy, Plenum Press, New York, 121-126, 1996.
28. Scobie M, Threadgill MD: Synthesis of carborane-containing nitroimidazole compounds via mild 1,3-dipolar cycloaddition. J Chem Soc, Chem Comm 13: 939-941, 1992
29. Hariharan JR, Wyzlic IM, Soloway AH: Synthesis of novel boron-containing polyamines agents for DNA targeting in neutron capture therapy. Polyhedron 14: 823-825, 1995
30. Feakes DA, Shelly KJ, Hawthorne MF, Schmidt PG, Elstad CA, Meadows GG, Bauer WF: Liposomal delivery of boron to murine tumors for boron neutron capture therapy. In: Soloway AH, Barth RF, Carpenter D E (eds) Advances in Neutron Capture Therapy. Plenum Press, New York 395-398, 1993
31. Kahl SB, Pate DW, Waunschel LA: Low density lipoprotein reconstitutions with alkyl and aryl carboranes. In: Soloway AH, Barth RF, Carpenter DE (eds) Advances in Neutron Capture Therapy. Plenum Press, New York 399-402, 1993
32. Spielvogel BF, Sood A, Powell W, Tomasz J, Porter K, Shaw BR: Chemical and enzymatic incorporation of boron into DNA. In: Soloway AH, Barth RF, Carpenter DE (eds) Advances in Neutron Capture Therapy. Plenum Press, New York 389-393, 1993
33. Liu L, Barth RF, Adams DM, Soloway AH, Reisfeld RA: Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors. J Hematotherapy 4: 477-483, 1995
34. Capala J, Barth RF, Bendayan M, Lauzon M, Adams DM, Soloway AH, Fenstermaker RA, Carlsson J: Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors. Bioconjugate Chem 7: 7-15, 1996
35. Yang W, Barth RF, Carpenter DE, Moeschberger ML, Goodman JH: Enhanced delivery of boronophenylalanine by means of intracarotid injection and blood-brain barrier disruption for neutron capture therapy. Neurosurgery 38: 985-992, 1996
36. Rief H, Van Heusden R, Perlini G: Generating epithermal neutron beams for neutron capture therapy in small reactors. In: Soloway AH, Barth RF, Carpenter DE (eds) Advances in Neutron Capture Therapy. Plenum Press, New York 85-88, 1993
37. 235U fission plates at the Brookhaven Medical Research Reactor. Med Physics 21: 1627-1631, 1994
38. Maruyama Y, Wierzbicki J, Feola JM: Cf-252 neutrons for the treatment of superficial carcinomas. In: Soloway AH, Barth RF, Carpenter DE (eds) Advances in Neutron Capture Therapy. Plenum Press, New York 135-137, 1993
39. Wang CK, Blue TE, Gahbauer RA: A neutronic study of an accelerator-based neutron irradiation facility for boron neutron capture therapy. Nucl Tech 84: 93-107, 1989
40. Yanch JC, Shefer RE, Hughey BJ, Klinkowstein RE: Accelerator-based epithermal neutron beams for neutron capture therapy. In: Soloway AH, Barth RF, Carpenter DE (eds) Advances in Neutron Capture Therapy. Plenum Press, New York 95-98, 1993
41. Gavin PR, DeHaan CE, Moore MP, Weidner JP, Swartz CD, Kraft SL, Atkinson CA, Amaro CR, Bauer WF, Siefert A: Large animal studies on the use of BNCT for the treatment of brain tumors. In: Soloway AH, Barth RF, Carpenter DE (eds) Advances in Neutron Capture Therapy. Plenum Press, New York 469-475, 1993
42. Gavin PR, Kraft SL, Huiskamp R, Codesse JA: A review: CNS effects and normal tissue tolerance in dogs. J Neurooncol (in press)
43. Gahbauer RA, Fairchild RG, Goodman JH, Blue TE: RBE in normal tissue studies. In: Gabel D, Moss R (eds) Neutron Capture Therapy. Plenum Press. New York, 123-128, 1992